Skip to content
Screener

Fennec Pharmaceuticals FENC Q4 2025 Annual earnings

Reported March 24, 2026 · Before market open

Revenue$13.8MMiss by $855.2K
EPS-$0.11Miss by $0.14
Revenue estimate$14.7M
EPS estimate$0.03

Next report

Date not yet announced

FAQ

When did Fennec Pharmaceuticals report Q4 2025 earnings?
Fennec Pharmaceuticals (FENC) reported Q4 2025 earnings on March 24, 2026 before market open.
What were Fennec Pharmaceuticals's Q4 2025 revenue and EPS?
Fennec Pharmaceuticals reported revenue of $13.8M and eps of $-0.11 for Q4 2025.
Did Fennec Pharmaceuticals beat estimates in Q4 2025?
Revenue missed the consensus estimate of $14.7M by $855.2K. EPS missed the consensus estimate of $0.03 by $0.14.
How did Fennec Pharmaceuticals's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 74.3% from $7.9M a year earlier and eps declined 83.3% from $-0.06.
Where can I find Fennec Pharmaceuticals's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001104659-26-033885) and the 10-K periodic report (0001104659-26-036182) directly on SEC EDGAR. The filing index links above go to sec.gov.